A study published in Nature Medicine shows MDMA-assisted therapy significantly reduces symptoms in individuals with severe PTSD, offering promising results for those unresponsive to traditional treatments, and is well-tolerated with few side effects.
A new study provides evidence that the lingering effects of hallucinogenic drugs, known as Hallucinogen Persisting Perception Disorder (HPPD), are more common among users than previously understood.
Stanford researchers found that a combination of magnesium and ibogaine significantly reduced symptoms of PTSD, depression, and anxiety in veterans with traumatic brain injuries. The treatment also improved cognitive functions.
A study analyzed Reddit posts to investigate how psilocybin affects self-perception and recognition in mirror gazing, finding it tends to enhances positive self-perception without impairing self-recognition.
Recent psychedelic research shows promising results for mental illnesses and eating disorders, with surveys and reports indicating psilocybin-assisted therapy's potential. However, challenges in research methodology, patient safety concerns, and the need for cautious optimism highlight the gap between scientific evidence...
A study in Brazil examines the spiritual well-being of psychedelic users and non-users, revealing distinct experiences and emphasizing the need for inclusive spirituality assessment tools.
Psilocybin-assisted group therapy might help reduce depression in cancer patients. This innovative approach, blending psychedelic effects with psychological support, has demonstrated promising results in improving mental health and quality of life for these patients.
New research published in Scientific Reports provides insights into the long-term negative psychological effects of psychedelic drugs. The study helps to identify potential risk factors for persistent anxiety, panic, and other psychological issues following the use of substances such as...
Scientists at Enveric Biosciences have created novel psilocybin derivatives, potentially offering therapeutic mental health benefits with reduced psychedelic effects. This research paves the way for new treatments for depression and anxiety.
Research from Toronto Western Hospital shows psilocybin-assisted psychotherapy as a promising treatment for major depression and cancer-related distress, calling for urgent advanced clinical trials. This innovative approach combines psychedelic mushrooms with guided therapy, offering new hope in mental health.
New research suggests a single dose of psilocybin, combined with psychotherapy, could significantly reduce depression in individuals with bipolar II disorder, maintaining these effects for 12 weeks. This innovative approach, contrasting sharply with self-medication, highlights the potential of controlled psychedelic...
Adults with ADHD who practiced microdosing psychedelics reported increased mindfulness after four weeks, according to a study in Frontiers in Psychiatry. The research highlights the need for controlled studies to validate these findings
A new study has found a link between psilocybin use and lowered psychological distress, particularly in individuals with adverse childhood experiences, highlighting the possible therapeutic applications of psychedelics.
A recent study explored the enduring challenges individuals face after using psychedelic substances like psilocybin and LSD, finding that emotional difficulties, such as anxiety and fear, were the most common, along with self-perception and cognitive issues. The study, published in...
A three-month study on ayahuasca ritual participants showed slight self-reported decreases in narcissism, not confirmed by informant reports. This research, highlighting ayahuasca's potential psychological impacts, suggests modest changes in personality traits and calls for further investigation into psychedelic-assisted therapies.